Gujarat Terce Laboratories Limited (GUJTERC) Share Price
BSE · Healthcare · Drug Manufacturers - Specialty & Generic · ISIN INE499G01013
Key metrics
- Market Cap
- ₹30 Cr
- P/E Ratio
- 13.95
- EPS
- 2.75
- Book Value
- 12.49
- P/B Ratio
- 3.07
- ROE
- 22.63%
- ROCE
- 30.66%
- Debt / Equity
- 0.13
- Net Margin
- 4.64%
- Revenue Growth
- -5.42%
- Profit Growth
- 324.98%
- Dividend Yield
- —
- 52W High
- ₹59.78
- 52W Low
- ₹29.00
- Market Cap Band
- micro cap
- Face Value
- —
Ratios computed from the annual results period ending 2026-03-31.
About Gujarat Terce Laboratories Limited
Gujarat Terce Laboratories Limited develops, manufactures, markets, and distributes medicines and healthcare products in India and internationally. The company offers generic pharmaceutical for therapeutic areas, such as antibiotics, respiratory, nutraceuticals, gastrology, gynecology, pain therapy, and ayurvedic. It provides tablets, capsules, oral liquids, ointments, and injections under the Acolate, Tynol, Resplash, Ferlit, Z-Oxi, Vitfol, Thyter, Aziter, and Codimol brands. Gujarat Terce Laboratories Limited was incorporated in 1985 and is based in Ahmedabad, India.
- Headquarters
- Ahmedabad, India
- Employees
- 234
- Promoter Holding
- 44.68%
The full Gujarat Terce Laboratories Limited analysis
Create a free account to open the complete GUJTERC deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.